Literature DB >> 1331785

Cloning and characterization of the gene encoding Trypanosoma cruzi DNA topoisomerase II.

S P Fragoso1, S Goldenberg.   

Abstract

The gene encoding Trypanosoma cruzi type II topoisomerase (TcTOP2) was isolated from a genomic library with a heterologous probe corresponding to part of the Trypanosoma brucei type II topoisomerase (TBrTOP2) gene. Nucleotide sequencing of TcTOP2 showed that the gene consists of an open reading frame of 3696 nucleotides (1232 amino acids), predicting a polypeptide product of 138,413 Da. Comparison of the amino acid sequence with that of type II topoisomerases from T. brucei (TBrTOP2) and Crithidia fasciculata (CfaTOP2), shows a high degree of conservation with estimated identities of 78% and 69%, respectively. TcTOP2 is a single copy gene in the genome of T. cruzi Dm28c and is expressed as a 4.5-kb mRNA. PCR mapping showed two distinct mini-exon addition sites at positions 225 and 203 upstream from the initiator AUG.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331785     DOI: 10.1016/0166-6851(92)90133-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  15 in total

1.  The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.

Authors:  Danielle P Cavalcanti; Stênio P Fragoso; Samuel Goldenberg; Wanderley de Souza; Maria Cristina M Motta
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

2.  Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.

Authors:  A Das; A Dasgupta; S Sharma; M Ghosh; T Sengupta; S Bandopadhyay; H K Majumder
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Localization of a DNA topoisomerase II to mitochondria inDictyostelium discoideum: Deletion mutant analysis and mitochondrial targeting signal presequence.

Authors:  K Komori; F Maruo; T Morio; H Urushihara; Y Tanaka
Journal:  J Plant Res       Date:  1997-03       Impact factor: 2.629

4.  In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles.

Authors:  T A Shapiro; A F Showalter
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

5.  Identification, molecular and functional characterization of calmodulin gene of Phytomonas serpens 15T that shares high similarity with its pathogenic counterparts Trypanosoma cruzi.

Authors:  Tatiana de Arruda Campos Brasil de Souza; Viviane Krominski Graça-de Souza; César Armando Contreras Lancheros; Viviane Monteiro-Góes; Marco Aurélio Krieger; Samuel Goldenberg; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

6.  Drug targets in Leishmania.

Authors:  Bhavna Chawla; Rentala Madhubala
Journal:  J Parasit Dis       Date:  2010-10-08

7.  Trypanosoma cruzi: molecular characterization of an RNA binding protein differentially expressed in the parasite life cycle.

Authors:  Leticia Pérez-Díaz; María Ana Duhagon; Pablo Smircich; José Sotelo-Silveira; Carlos Robello; Marco Aurelio Krieger; Samuel Goldenberg; Noreen Williams; Bruno Dallagiovanna; Beatriz Garat
Journal:  Exp Parasitol       Date:  2007-03-27       Impact factor: 2.011

8.  Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation.

Authors:  T A Shapiro
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.

Authors:  A L Bodley; T A Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Chhabinath Mandal; Aditi Das; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.